Breaking News Instant updates and real-time market news.

FL

Foot Locker

$52.85

-1.355 (-2.50%)

09:11
05/24/19
05/24
09:11
05/24/19
09:11

Foot Locker says focused on a 'more premium apparel strategy'

Says 2019 has gotten over to a "solid start". Says saw gains in all regions and channels. Says footwear was the strongest category. Says in accessories, bags were strong, but socks and hats saw a decline. Says drivers were broad-based. Says apparel was led by men's business, while women's and children's was down. Says men's short business picked up. Says making strategic investments in digital capabilities, store fleet and infrastructure. Comments taken from Q1 earnings conference call.

  • 24

    May

  • 09

    Jul

FL Foot Locker
$52.85

-1.355 (-2.50%)

05/17/19
RILY
05/17/19
UPGRADE
Target $73
RILY
Buy
Foot Locker upgraded to Buy from Neutral at B. Riley FBR
B. Riley FBR analyst Susan Anderson upgraded Foot Locker to Buy from Neutral and raised her price target for the shares to $73 from $62. The analyst views Foot Locker as a "best-in-class" footwear retailer and sees an attractive entry point at current valuation levels.
05/17/19
LEHM
05/17/19
NO CHANGE
Target $85
LEHM
Overweight
Barclays an 'aggressive' buyer of Foot Locker into Q1 earnings
Barclays analyst Matthew McClintock says he's an "aggressive" buyer of Foot Locker shares into the company's Q1 results. While some comp expectations have declined over the last few months, the analyst is still expecting Foot Locker to comp in line with the company's long-term algorithm of positive mid-single-digits. He sees no reason why Foot Locker's comp store sales should have meaningfully decelerated from last quarter's near 10% comp. McClintock keeps an Overweight rating on the shares with an $85 price target.
05/17/19
05/17/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Foot Locker (FL) upgraded to Buy from Neutral at B. Riley FBR with analyst Susan Anderson saying she views Foot Locker as a "best-in-class" footwear retailer and sees an attractive entry point at current valuation levels. 2. Under Armour (UA, UAA) upgraded to Overweight from Neutral at JPMorgan with analyst Matthew Boss citing his meeting with management, including CEO Kevin Plank, and saying the clear tone from the top was "controlled confidence" in the brand direction with "disciplined" fiscal 2020 global top- and bottom-line growth acceleration. 3. Philip Morris (PM) upgraded to Neutral from Underperform at BofA/Merrill with analyst Lisa Lewandowski saying IQOS, the company's heated tobacco product, is gaining traction in several European and Asian markets, the FDA approved the pre-market application for the sale of IQOS in the U.S., and management has reset IQOS commercialization expectations, among other reasons. 4. Walmart (WMT) upgraded to Accumulate from Hold at Gordon Haskett with analyst Chuck Grom saying he believes the company's EBIT gains in the U.S. will continue. 5. United Therapeutics (UTHR) upgraded to Neutral from Sell at UBS with analyst Carter Gould saying that after a 26% stock price decline since late March, when Sandoz launched generic Remodulin, the risk reward on the stock has become more balanced. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/23/19
ADAM
05/23/19
NO CHANGE
ADAM
Canaccord says buyers into Foot Locker's Q1 earnings report
Canaccord analyst Camilo Lyon reiterated a Buy rating and $82 price target on Foot Locker ahead of the company's Q1 earnings report, saying he sees the recent pullback in shares as a buying opportunity, and believes a "strong product assortment" from Nike (NKE) and Jordan drove mid-single-digit Q1 comps "despite buyside expectations that appear to have become too negatively skewed in suggesting comps could be flat to up modestly." The analyst believes that if the company delivers the comp growth it forecasts, the stock should rebound sharply,

TODAY'S FREE FLY STORIES

UNP

Union Pacific

$166.97

-0.16 (-0.10%)

07:29
06/17/19
06/17
07:29
06/17/19
07:29
Downgrade
Union Pacific rating change  »

Union Pacific downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYB

LyondellBasell

07:27
06/17/19
06/17
07:27
06/17/19
07:27
Downgrade
LyondellBasell rating change  »

Deutsche downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCYC

Bicycle Therapeutics

$13.00

0.61 (4.92%)

07:27
06/17/19
06/17
07:27
06/17/19
07:27
Initiation
Bicycle Therapeutics initiated  »

Bicycle Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPP

WPP

$60.56

-0.24 (-0.39%)

07:27
06/17/19
06/17
07:27
06/17/19
07:27
Hot Stocks
WPP to phase out single-use plastics »

WPP announced a series of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VEEV

Veeva

$164.70

-1.555 (-0.94%)

07:26
06/17/19
06/17
07:26
06/17/19
07:26
Conference/Events
Veeva management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 23

    Jun

SYF

Synchrony

$33.95

-0.05 (-0.15%)

07:25
06/17/19
06/17
07:25
06/17/19
07:25
Hot Stocks
Synchrony reports May net charge-off rate 4.91% vs. 5.11% last month »

Reports May 30-plus day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$77.76

1.385 (1.81%)

07:25
06/17/19
06/17
07:25
06/17/19
07:25
Conference/Events
Incyte to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

PSTI

Pluristem

$0.56

0.0001 (0.02%)

07:24
06/17/19
06/17
07:24
06/17/19
07:24
Hot Stocks
Pluristem presents its first proprietary serum-free cell therapy product »

Pluristem Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

H

Hyatt

$74.68

-0.185 (-0.25%)

07:24
06/17/19
06/17
07:24
06/17/19
07:24
Hot Stocks
Hyatt announces plan for first Alila resort in Europe »

Hyatt announced that a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TREE

LendingTree

$386.02

-1.83 (-0.47%)

07:24
06/17/19
06/17
07:24
06/17/19
07:24
Conference/Events
LendingTree management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

  • 27

    Jun

  • 13

    Nov

TTEC

TTEC Holdings

$44.26

0.65 (1.49%)

07:23
06/17/19
06/17
07:23
06/17/19
07:23
Recommendations
TTEC Holdings analyst commentary  »

TTEC Holdings price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EB

Eventbrite

$16.00

-0.41 (-2.50%)

07:22
06/17/19
06/17
07:22
06/17/19
07:22
Initiation
Eventbrite initiated  »

Eventbrite initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSTM

Verastem

$1.39

0.125 (9.88%)

07:22
06/17/19
06/17
07:22
06/17/19
07:22
Hot Stocks
Verastem presents Copiktra clinical data at EHA »

Verastem announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STL

Sterling Bancorp

$20.36

-0.01 (-0.05%)

07:21
06/17/19
06/17
07:21
06/17/19
07:21
Conference/Events
Sterling Bancorp management to meet with Sandler ONeill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

TC

TuanChe

$2.96

0.065 (2.25%)

07:21
06/17/19
06/17
07:21
06/17/19
07:21
Hot Stocks
TuanChe announces up to $20M share repurchase program »

TuanChe announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THO

Thor Industries

$54.30

-0.01 (-0.02%)

, UNFI

United Natural Foods

$10.28

-0.51 (-4.73%)

07:20
06/17/19
06/17
07:20
06/17/19
07:20
Recommendations
Thor Industries, United Natural Foods analyst commentary  »

Citi lowers price targets…

THO

Thor Industries

$54.30

-0.01 (-0.02%)

UNFI

United Natural Foods

$10.28

-0.51 (-4.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

AYX

Alteryx

$104.23

2.08 (2.04%)

07:19
06/17/19
06/17
07:19
06/17/19
07:19
Recommendations
Alteryx analyst commentary  »

Alteryx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRCL

Stericycle

$45.24

-0.41 (-0.90%)

07:19
06/17/19
06/17
07:19
06/17/19
07:19
Conference/Events
Stericycle management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

  • 21

    Aug

BWEN

Broadwind Energy

$2.17

0.02 (0.93%)

07:18
06/17/19
06/17
07:18
06/17/19
07:18
Hot Stocks
Broadwind Energy announces $29M of new tower orders »

Broadwind Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$8.24

-0.37 (-4.30%)

07:17
06/17/19
06/17
07:17
06/17/19
07:17
Recommendations
Teva analyst commentary  »

Citi removes Teva from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REVG

REV Group

$12.99

-0.555 (-4.10%)

07:17
06/17/19
06/17
07:17
06/17/19
07:17
Recommendations
REV Group analyst commentary  »

REV Group price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIXX

Homology Medicines

$18.56

0.16 (0.87%)

07:16
06/17/19
06/17
07:16
06/17/19
07:16
Hot Stocks
Homology Medicines says single dose HMI-102 resulted in long-term PKU correction »

Homology Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNV

Synovus

$33.01

0.08 (0.24%)

07:15
06/17/19
06/17
07:15
06/17/19
07:15
Conference/Events
Synovus management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

ARRY

Array BioPharma

$29.59

0.17 (0.58%)

, PFE

Pfizer

$42.75

0.24 (0.56%)

07:14
06/17/19
06/17
07:14
06/17/19
07:14
Hot Stocks
Breaking Hot Stocks news story on Array BioPharma, Pfizer »

Array BioPharma up 59% to…

ARRY

Array BioPharma

$29.59

0.17 (0.58%)

PFE

Pfizer

$42.75

0.24 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 16

    Sep

ALNY

Alnylam

$70.04

-1.15 (-1.62%)

07:14
06/17/19
06/17
07:14
06/17/19
07:14
Hot Stocks
Alnylam announces lumasiran results, full patient enrollment in ILLUMINATE-A, »

Alnylam announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.